Biomarin Pharmaceutical Stock Momentum Indicators Aroon
| BMRN Stock | USD 71.24 0.36 0.50% |
| Symbol |
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Aroon Indicator was developed by Tushar S. Chande to indicate when a new trend is dawning. The indicator consists of two lines that measure how long it has been since the highest high/lowest low has occurred within an (N) period range. When Biomarin Pharmaceutical Aroon Up is staying between 70 and 100 then it indicates an upward trend. When the Aroon Down is staying between 70 and 100 then it indicates an downward trend. A strong upward trend is indicated when the Aroon Up is above 70 while the Aroon Down is below 30. When Biomarin Pharmaceutical Aroon Down crosses above the Aroon Up, it indicates a weakening of the upward trend (and vice versa).
Biomarin Pharmaceutical Technical Analysis Modules
Most technical analysis of Biomarin Pharmaceutical help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Biomarin from various momentum indicators to cycle indicators. When you analyze Biomarin charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Biomarin Pharmaceutical Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Biomarin Pharmaceutical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Biomarin Pharmaceutical based on widely used predictive technical indicators. In general, we focus on analyzing Biomarin Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Biomarin Pharmaceutical's daily price indicators and compare them against related drivers, such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Biomarin Pharmaceutical's intrinsic value. In addition to deriving basic predictive indicators for Biomarin Pharmaceutical, we also check how macroeconomic factors affect Biomarin Pharmaceutical price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2022 | 2023 | 2024 | 2025 (projected) | Days Sales Outstanding | 80.33 | 95.61 | 84.48 | 96.31 | PTB Ratio | 4.17 | 3.66 | 2.21 | 3.91 |
Align your values with your investing style
In addition to having Biomarin Pharmaceutical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Cancer Fighters Invested over 90 shares | |
 | Air Invested over 400 shares | |
 | Macroaxis Index Invested over 200 shares | |
 | Gold and Gold Mining Invested over 20 shares | |
 | Precious Metals Invested over 100 shares | |
 | Driverless Cars Invested over 300 shares | |
 | SRI Sustainable Growth Invested few shares | |
 | Warren Buffett Holdings Invested few shares | |
 | Dividend Beast Invested over 60 shares | |
 | Hedge Favorites Invested over 60 shares |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomarin Pharmaceutical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Biomarin Stock, please use our How to Invest in Biomarin Pharmaceutical guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomarin Pharmaceutical. If investors know Biomarin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomarin Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 6.449 | Earnings Share 2.21 | Revenue Per Share | Quarterly Revenue Growth 0.156 | Return On Assets |
The market value of Biomarin Pharmaceutical is measured differently than its book value, which is the value of Biomarin that is recorded on the company's balance sheet. Investors also form their own opinion of Biomarin Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Biomarin Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomarin Pharmaceutical's market value can be influenced by many factors that don't directly affect Biomarin Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomarin Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomarin Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomarin Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.